AstraZeneca (AZN)

Add to Watchlists Create an Alert
76.06 +1.82  +2.45% NYSE Aug 29, 4:59PM BATS Real time Currency in USD

AstraZeneca Return on Equity (TTM):

8.93% for June 30, 2014

View 4,000+ financial data types

View Full Chart

AstraZeneca Return on Equity (TTM) Chart

Export Data
Save Image

AstraZeneca Historical Return on Equity (TTM) Data

View and export this data going back to 1993. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 8.93%
March 31, 2014 9.03%
Dec. 31, 2013 11.04%
Sept. 30, 2013 20.03%
June 30, 2013 21.41%
March 31, 2013 25.21%
Dec. 31, 2012 27.72%
Sept. 30, 2012 27.58%
June 30, 2012 35.80%
March 31, 2012 37.95%
Dec. 31, 2011 42.90%
Sept. 30, 2011 43.91%
June 30, 2011 36.11%
March 31, 2011 37.03%
Dec. 31, 2010 37.00%
Sept. 30, 2010 38.02%
June 30, 2010 42.48%
March 31, 2010 43.38%
Dec. 31, 2009 42.18%
Sept. 30, 2009 42.65%
June 30, 2009 42.08%
March 31, 2009 43.18%
Dec. 31, 2008 39.37%
Sept. 30, 2008 40.16%
June 30, 2008 38.25%
   
March 31, 2008 38.00%
Dec. 31, 2007 38.09%
Sept. 30, 2007 39.27%
June 30, 2007 40.77%
March 31, 2007 42.65%
Dec. 31, 2006 41.89%
Sept. 30, 2006 41.62%
June 30, 2006 39.71%
March 31, 2006 37.67%
Dec. 31, 2005 34.45%
Sept. 30, 2005 31.88%
June 30, 2005 31.27%
March 31, 2005 28.35%
Dec. 31, 2004 26.76%
Sept. 30, 2004 24.86%
June 30, 2004 22.99%
March 31, 2004 22.25%
Dec. 31, 2003 24.07%
Sept. 30, 2003 23.13%
June 30, 2003 23.05%
March 31, 2003 24.92%
Dec. 31, 2002 26.35%
Sept. 30, 2002 30.27%
June 30, 2002 31.83%
March 31, 2002 31.79%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Get data for
Advertisement

AZN Return on Equity (TTM) Benchmarks

Companies
GlaxoSmithKline 73.47%
Eli Lilly 19.71%
Pfizer 13.43%

AZN Return on Equity (TTM) Range, Past 5 Years

Minimum 8.93% Jun 2014
Maximum 43.91% Sep 2011
Average 31.52%

AZN Return on Equity (TTM) Excel Add-In Codes

  • Metric Code: return_on_equity
  • Latest data point: =YCP("AZN", "return_on_equity")
  • Last 5 data points: =YCS("AZN", "return_on_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.